Erythropoietin Enhances Neovascularization of Ischemic Myocardium and Improves Left Ventricular Dysfunction After Myocardial Infarction in Dogs
- 4 July 2006
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 48 (1), 176-184
- https://doi.org/10.1016/j.jacc.2006.04.008
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Erythropoietin Induces Neovascularization and Improves Cardiac Function in Rats With Heart Failure After Myocardial InfarctionJournal of the American College of Cardiology, 2005
- Erythropoietin Just Before Reperfusion Reduces Both Lethal Arrhythmias and Infarct Size via the Phosphatidylinositol-3 Kinase-Dependent Pathway in Canine HeartsCardiovascular Drugs and Therapy, 2005
- Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarctionBlood, 2005
- Erythropoietin regulates endothelial progenitor cellsBlood, 2004
- Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid CommunicationKidney International, 2003
- Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilizationBlood, 2003
- Plasma Vascular Endothelial Growth Factor Concentrations in Healthy Dogs and Dogs with HemangiosarcomaJournal of Veterinary Internal Medicine, 2001
- Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990–1996Kidney International, 1998
- Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.JCI Insight, 1994
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Cell Metabolism, 1977